• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

SW-100

CAS No. 2126744-35-0

SW-100 ( SW100;SW 100 )

产品货号. M13382 CAS No. 2126744-35-0

SW-100 (SW100) is a potent, selective, brain penetrable HDAC6 inhibitor with IC50 of 2.3 nM.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥599 有现货
5MG ¥988 有现货
10MG ¥1596 有现货
25MG ¥2657 有现货
50MG ¥3961 有现货
100MG ¥5775 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    SW-100
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    SW-100 (SW100) is a potent, selective, brain penetrable HDAC6 inhibitor with IC50 of 2.3 nM.
  • 产品描述
    SW-100 (SW100) is a potent, selective, brain penetrable HDAC6 inhibitor with IC50 of 2.3 nM, displays >1,000-fold selectivity over all other class I, II, and IV HDAC isoforms; selectively inhibits HDAC6-CD2 and enhances α-tubulin acetylation in cells with no effect on histone acetylation and selectively restores the impaired acetylated α-tubulin levels in the hippocampus of Fmr1-/- mice; ameliorates several memory and learning impairments in Fmr1-/- mice, thus modeling the intellectual deficiencies associated with Fragile X syndrome (FXS).
  • 同义词
    SW100;SW 100
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    HDAC
  • 受体
    HDAC
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2126744-35-0
  • 分子量
    316.79
  • 分子式
    C17H17ClN2O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : ≥ 125 mg/mL 394.60 mM
  • SMILES
    C1CC2=C(C=CC(=C2)Cl)N(C1)CC3=CC=C(C=C3)C(=O)NO
  • 化学全称
    4-((6-chloro-3,4-dihydroquinolin-1(2H)-yl)methyl)-N-hydroxybenzamide

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Kozikowski A, et al. ACS Chem Neurosci. 2018 Dec 4. doi: 10.1021/acschemneuro.8b00600.
产品手册
关联产品
  • Ledipasvir

    Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.

  • Nexturastat A

    A potent and selective HDAC6 inhibitor with IC50 of 5 nM.

  • Encorafenib

    LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.